Search research articles
Contact Us
Filters
Showing results (131-140 of 138) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 138 results.
Pediatrics
|
May 3, 2026
Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial
Christina A Rostad, C Mary Healy, Jennifer L Nayak, et al.
Vaccine
|
January 5, 2025
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens
Hana M El Sahly, Evan J Anderson, Lisa A Jackson, et al.
Research Square
|
May 13, 2022
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine - An Interim Analysis
Evan Anderson, Lisa Jackson, Nadine Rouphael, et al.
The New England Journal of Medicine
|
December 30, 2020
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Lindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
The New England Journal of Medicine
|
October 19, 2022
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age
Evan J Anderson, C Buddy Creech, Vladimir Berthaud, et al.
Vaccine
|
July 27, 2025
Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkers
Joann Diray-Arce, Ana C Chang, Sara Moradipoor, et al.
The New England Journal of Medicine
|
May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final Report
John H Beigel, Kay M Tomashek, Lori E Dodd, et al.
Medicine
|
November 9, 2010
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency
Capucine Picard, Horst von Bernuth, Pegah Ghandil, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 138) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 138 results.
Pediatrics
|
May 3, 2026
Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial
Christina A Rostad, C Mary Healy, Jennifer L Nayak, et al.
Vaccine
|
January 5, 2025
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens
Hana M El Sahly, Evan J Anderson, Lisa A Jackson, et al.
Research Square
|
May 13, 2022
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine - An Interim Analysis
Evan Anderson, Lisa Jackson, Nadine Rouphael, et al.
The New England Journal of Medicine
|
December 30, 2020
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Lindsey R Baden, Hana M El Sahly, Brandon Essink, et al.
The New England Journal of Medicine
|
October 19, 2022
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age
Evan J Anderson, C Buddy Creech, Vladimir Berthaud, et al.
Vaccine
|
July 27, 2025
Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkers
Joann Diray-Arce, Ana C Chang, Sara Moradipoor, et al.
The New England Journal of Medicine
|
May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final Report
John H Beigel, Kay M Tomashek, Lori E Dodd, et al.
Medicine
|
November 9, 2010
Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency
Capucine Picard, Horst von Bernuth, Pegah Ghandil, et al.
Page
of 14